[1]尹飞,李菲,李志红.亚临床甲状腺功能异常与骨质疏松[J].国际内分泌代谢杂志,2015,(04):258-260.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
 Yin Fei,Li Fei,Li Zhihong..Subclinical thyroid dysfunction and osteoporosis[J].International Journal of Endocrinology and Metabolism,2015,(04):258-260.[doi:10.3760/cma.j.issn.1673-4157.2015.04.012]
点击复制

亚临床甲状腺功能异常与骨质疏松()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2015年04
页码:
258-260
栏目:
甲状腺疾病专栏
出版日期:
2015-07-20

文章信息/Info

Title:
Subclinical thyroid dysfunction and osteoporosis
作者:
尹飞李菲李志红
071000 河北省保定市第一中心医院内分泌科
Author(s):
Yin FeiLi FeiLi Zhihong.
Department of Endocrinology,Baoding NO.1 Central Hospital,Baoding 071000,China Corresponding author:Li Zhihong,Email:lizhihonglfz@126.com
关键词:
亚临床甲状腺功能减退症亚临床甲状腺功能亢进症促甲状腺激素骨质疏松
Keywords:
Subclinical hypothyroidismSubclinical hyperthyroidismThyroid-stimulating hormoneOsteoporosis
DOI:
10.3760/cma.j.issn.1673-4157.2015.04.012
摘要:
亚临床甲状腺功能异常(STD)和骨质疏松是常见的内分泌疾病,主要发生在女性和老年人群中。甲状腺激素和促甲状腺激素可直接或间接影响骨代谢,导致骨密度发生变化。而STD患者体内这两种激素水平异常,提示STD和骨质疏松之间存在一定的联系。此外,外源性甲状腺激素替代治疗亦可影响骨代谢,导致骨密度下降和骨质疏松。因此,明确STD和骨质疏松之间的联系并采取适当干预措施对于预防STD患者发生骨质疏松有重要意义。
Abstract:
Both subclinical thyroid dysfunction(STD)and osteoporosis are common endocrine diseases which affect female and the elderly population mainly. Thyroid hormone and thyroid-stimulating hormone(TSH) can affect bone metabolism directly or indirectly,leading to changes in bone mineral density.Both thyroid hormone and thyroid-stimulating hormone are abnormd in STD patients which suggests an association between STD and osteoporosis. In addition,thyroid hormone replacement therapy may also affect bone metabolism,resulting in a reduction of bone mineral density and osteoporosis.Therefore,uncovering the relationship between STD and osteoporosis and taking appropriate intervention to improve the living quality of patients with STD are of great importance.

参考文献/References:

[1] Sun L,Vukicevic S,Baliram R,et al.Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss[J].Proc Natl Acad Sci U S A,2008,105(11):4289-4294.  
[2] Williams GR.Does serum TSH level have thyroid hormone inde-pendent effects on bone turnover?[J].Nat Clin Pract Endocrinol Metab,2009,5(1):10-11.  
[3] Nicholls JJ,Brassill MJ,Williams GR,et al.The skeletal conse-quences of thyrotoxicosis[J].J Endocrinol,2012,213(3):209-221.  
[4] Bauer DC,Ettinger B,Nevitt MC,et al.Risk for fracture in women with low serum levels of thyroid-stimulating hormone[J].Ann Intern Med,2001,134(7):561-568.  
[5] Lee JS,Buzková P,Fink HA,et al.Subclinical thyroid dysfunction and incident hip fracture in older adults[J].Arch Intern Med, 2010,170(21):1876-1883.  
[6] Garin MC,Arnold AM,Lee JS,et al.Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults:the cardiovascular health study[J].J Clin Endocrinol Metab,2014, 99(8):2657-2664.  
[7] Leader A,Ayzenfeld RH,Lishner M,et al.Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women,but not men,over the age of 65 years[J].J Clin Endocrinol Metab,2014,99(8):2665-2673.  
[8] Bassett JH,O'Shea PJ,Sriskantharajah S,et al.Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism[J].Mol Endocrinol,2007,21(5):1095-1107.  
[9] van der Deure WM,Uitterlinden AG,Hofman A,et al.Effects of serum TSH and FT4 1evels and the TSHR-Asp727Glu polymor-phism on bone:the Rotterdam Study[J].Clin Endocrinol(Oxf),2008,68(2):175-181.
[10] 戴耀宗,李立人.老年亚临床甲减患者骨代谢生化指标的变化[J].放射免疫学杂志,2005,18(1):41-42.
[11] Kooh SW,Brnjac L,Ehrlich RM,et al.Bone mass in children with congenital hypothyroidism treated with thyroxine since birth[J].J Pediatr Endocrinol Metab,1996,9(1):59-62.
[12] González-Rodríguez LA,Felici-Giovanini ME,Haddock L.Thyroid dysfunction in an adult female population:a population-based study of Latin American Vertebral Osteoporosis Study (LAVOS) - Puerto Rico site[J].P R Health Sci J,2013,32(2):57-62.
[13] Svare A,Nilsen TI,Asvold BO,et al.Does thyroid function influ-ence fracture risk? Prospective data from the HUNT2 study,Norway[J]. Eur J Endocrinol,2013,169(6):845-852.
[14] Noh HM,Park YS,Lee J,et al.A cross-sectional study to examine the correlation between serum TSH levels and the osteoporosis of the lumbar spine in healthy women with normal thyroid function[J].Osteoporos Int,2015,26(3):997-1003.
[15] Hyder JA,Allison MA,Barrett-Connor E,et al.Bone mineral density and atherosclerosis:the Multi-Ethnic Study of Atheroscle-rosis,Abdominal Aortic Calcium Study[J].Atherosclerosis,2010, 209(1): 283-289.
[16] Sennerby U,Melhus H,Gedeborg R,et al.Cardiovascular diseases and risk of hip fracture[J].JAMA,2009,302(15):1666-1673.
[17] Thompson B,Towler DA.Arterial calcification and bone physiology:role of the bone-vascular axis[J].Nat Rev Endocrinol,2012,8(9): 529-543.
[18] 苏青.美国甲状腺协会/美国临床内分泌医师协会甲亢诊疗指南介绍[J].中华内分泌代谢杂志,2013,29(2):后插1-后插5.
[19] Selmer C,Olesen JB,Hansen ML,et al.Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardio-vascular events:a large population study[J].J Clin Endocrinol Metab,2014,99(7):2372-2382.
[20] Karimifar M,Esmaili F,Salari A,et al.Effects of Levothyroxine and thyroid stimulating hormone on bone loss in patients with primary hypothyroidism[J].J Res Pharm Pract,2014,3(3):83-87.
[21] Van Rijn LE,Pop VJ,Williams GR.Low bone mineral density is related to high physiological levels of free thyroxine in peri-menopausal women[J].Eur J Endocrinol,2014,170(3):461-468.
[22] Tárraga López PJ,López CF,de Mora FN,et al.Osteoporosis in patients with subclinical hypothyroidism treated with thyroid hormone[J].Clin Cases Miner Bone Metab,2011,8(3):44-48.
[23] Garber GR,Cobin RH,Gharib H,et al.Clinical practice guide-lines for hypothyroidism in adults:cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association[J].Endocr Pract,2012,18(6):988-1028.

相似文献/References:

[1]孙敏讷,段宇.老年亚临床甲状腺功能减退症的诊治特点[J].国际内分泌代谢杂志,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
 Sun Minne,Duan Yu..Diagnositc and therapeutic characteristics of subclinical hypothyroidism in elderly people[J].International Journal of Endocrinology and Metabolism,2014,(04):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
[2]张建萍,孟召伟,谭建,等.甲状腺静态显像诊断双异位甲状腺的6年回顾性研究[J].国际内分泌代谢杂志,2015,(03):166.[doi:10.3760/cma.j.issn.1673-4157.2015.03.006]
 Zhang Jianping*,Meng Zhaowei,Tan Jian,et al.Scintigraphic detection of dual ectopic thyroid: a six-year retrospective study[J].International Journal of Endocrinology and Metabolism,2015,(04):166.[doi:10.3760/cma.j.issn.1673-4157.2015.03.006]
[3]田瑗 刘龙 王莹 崔兰.亚临床甲状腺功能减退症与冠心病及其危险因素的相关性研究[J].国际内分泌代谢杂志,2015,(05):298.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.003]
 Tian Yuan*,Liu Long,Wang Ying,et al.Correlation of subclinical hypothyroidism with coronary heart disease and its risk factors[J].International Journal of Endocrinology and Metabolism,2015,(04):298.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.003]
[4]王隽书 杨光燃.亚临床甲状腺功能减退症动物模型的研究进展[J].国际内分泌代谢杂志,2018,38(04):247.[doi:10.3760/cma.j.issn.1673-4157.2018.04.007]
 Wang Junshu,Yang Guangran..Recent progress of subclinical hypothyroidism animal models[J].International Journal of Endocrinology and Metabolism,2018,38(04):247.[doi:10.3760/cma.j.issn.1673-4157.2018.04.007]
[5]王珊珊 俞冰鸿 傅雯雯 杨艳辉 孔岩 王靖宇 常宝成 郑妙艳 杨菊红 王颖许杰 单春艳.亚临床甲状腺功能减退症与2型糖尿病肾功能损伤的相关性研究[J].国际内分泌代谢杂志,2019,39(06):368.[doi:10.3760/cma.j.issn.1673-4157.2019.06.002]
 Wang Shanshan,Yu Binghong,Fu Wenwen,et al.Correlation between subclinical hypothyroidism and renal function injury in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2019,39(04):368.[doi:10.3760/cma.j.issn.1673-4157.2019.06.002]

备注/Memo

备注/Memo:
基金项目:河北省自然科学基金资助项目(13967705D)   通信作者:李志红,Email:lizhihonglfz@126.com
更新日期/Last Update: 2015-07-20